From science to operations: Questions, choices and strategies for success in biopharma
| Book Excerpt
As biopharma products are moving from niche to mainstream, the industry is facing a paradigm shift in cost, quality, complexity, and scale—creating opportunities to develop new and different technologies and operating models. Achieving the next phase of the industry potential will require a further revolution, not only in the laboratory but also in strategy, technology, and operations. Decisions made today will affect companies' competitive positions years or even decades into the future.